If you are working in any of the following scientific/business topic areas, we encourage you to submit a proposal for a podium presentation. We are especially looking for case studies with new data on the following:

  • Antibody engineering, libraries and selection (including HTS)
  • Machine learning/artificial intelligence in antibody discovery and engineering
  • Fc-engineering & other (non IgG1/IgG4) subclasses
  • Antibody-drug conjugates, toxins and other conjugates
  • Cellular therapies: CART's (T and NK) (non-cell engaging)
  • Bispecifics / multispecifics / combinations (non-cell engaging)
  • Antibodies in Infectious diseases
  • T cell (including gamma/delta) and NK cell engagers
  • Advancing antibody therapeutics in immuno-oncology
  • Tumor microenvironment (including immunocytokines)
  • Novel/difficult targets for antibody therapeutics (e.g. MHCp, GPRC, glycans etc)
  • How to develop an antibody-based drug: from discovery to  IND?
  • Adaptive immune receptor repertoire data processing, annotation and interpretation
  • Antibodies in non-cancer (Autoimmune, neurological and other diseases)
  • Functional Screening Integrated Into Initial Antibody Discovery

Submit Your Proposal

Poster Hall Hours

Tuesday, May 10, 2016
3:00 pm - 6:30 pm

Wednesday, May 11, 2016
10:00 am - 6:30 pm

Thursday, May 12, 2016
10:30 am - 2:00 pm

Presentations should be free of commercial bias as well as any references to commercial products and services. All selected faculty are required to disclose the existence of any significant financial interest. Financial interest may affect the consideration of your presentation/proposal application.

You will be notified by the Event Review Committee if your presentation has been selected.

Call for Speakers

Deadline to submit is May 6, 2022

December 4 - 8, 2022
Marriott Marquis San Diego
San Diego, CA

December 4 - 8, 2022
Marriott Marquis San Diego
San Diego, CA

Antibody Engineering & Therapeutics

Terms and Conditions  |  Privacy Policy

† You may still receive emails from us regarding any current registrations or orders.